These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 18481028)

  • 1. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoid metabolic pathways and enzymes.
    Ligresti A; Cascio MG; Di Marzo V
    Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system in neurodegeneration.
    Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An introduction to the endocannabinoid system: from the early to the latest concepts.
    De Petrocellis L; Di Marzo V
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
    Ueda N; Tsuboi K; Uyama T; Ohnishi T
    Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid biosynthesis and inactivation, from simple to complex.
    Muccioli GG
    Drug Discov Today; 2010 Jun; 15(11-12):474-83. PubMed ID: 20304091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted lipidomics as a tool to investigate endocannabinoid function.
    Astarita G; Geaga J; Ahmed F; Piomelli D
    Int Rev Neurobiol; 2009; 85():35-55. PubMed ID: 19607960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.
    Placzek EA; Okamoto Y; Ueda N; Barker EL
    Neuropharmacology; 2008 Dec; 55(7):1095-104. PubMed ID: 18760289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous cannabinoids: structure and metabolism.
    Bisogno T
    J Neuroendocrinol; 2008 May; 20 Suppl 1():1-9. PubMed ID: 18426492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
    Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
    Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
    Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
    Sugiura T; Kobayashi Y; Oka S; Waku K
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of endocannabinoid synthesis system.
    Wang J; Ueda N
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):112-9. PubMed ID: 19126434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAAH and anandamide: is 2-AG really the odd one out?
    Di Marzo V; Maccarrone M
    Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
    Maccarrone M; Finazzi-Agró A
    Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight.
    Di Marzo V
    Nat Neurosci; 2011 Jan; 14(1):9-15. PubMed ID: 21187849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into endocannabinoid degradation and its therapeutic potential.
    Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
    Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
    Howlett AC; Reggio PH; Childers SR; Hampson RE; Ulloa NM; Deutsch DG
    Br J Pharmacol; 2011 Aug; 163(7):1329-43. PubMed ID: 21545414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids and their involvement in the neurovascular system.
    Battista N; Fezza F; Maccarrone M
    Curr Neurovasc Res; 2004 Apr; 1(2):129-40. PubMed ID: 16185189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical enzymes involved in endocannabinoid metabolism.
    Basavarajappa BS
    Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.